Zobrazeno 1 - 10
of 41
pro vyhledávání: '"K. Sivasubramani"'
Publikováno v:
Biochemical and Cellular Archives. 23:241-248
Autor:
Subhashree Jena, V. Dhithya, S. Harikrishnan, M. Mukilan, M. Parivallal, K. Sivasubramani, M. Kalaiselvam, S. Jayalakshmi
Publikováno v:
Biochemical and Cellular Archives. 23:309-316
Autor:
Christopher K. Cote, Jennifer E. Peel, Samandra T. Demons, Jennifer K Tran, Lynda L. Miller, Chi-Lee C. Ho, Satheesh K Sivasubramani, Chiu-Yen Kao, Jennifer L. Shoe, David P Fetterer, Mikhail Martchenko Shilman, Johnny W. Peterson, Gloria Bartolo, Ryan C. McComb, Saleem Alameh, Kenneth A. Bradley, David W.C. Beasley, Stella Hartmann, Emiene Amali-Adekwu, William S Lawrence, Anastasia Levitin, Marina Chugunova, Joel West, Leeor Zilbermintz, Christopher P. Klimko, Luisa W. Cheng, Aram Derbedrossian, Stephanie A Halasahoris
Publikováno v:
ACS Infect Dis
[Image: see text] Anthrax is caused by Bacillus anthracis and can result in nearly 100% mortality due in part to anthrax toxin. Antimalarial amodiaquine (AQ) acts as a host-oriented inhibitor of anthrax toxin endocytosis. Here, we determined the phar
Autor:
N. M. Korthagen, E. Houtman, I. Boone, R. Coutinho de Almeida, K. Sivasubramaniyan, R. Mahdad, R. G. H. H Nelissen, Y. F. M. Ramos, M. A Tessari, I. Meulenbelt
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-10 (2024)
Abstract Objective To characterize aspects of triiodothyronine (T3) induced chondrocyte terminal maturation within the molecular osteoarthritis pathophysiology using the previously established T3 human ex vivo osteochondral explant model. Designs RNA
Externí odkaz:
https://doaj.org/article/9807b18c1310450e9dc4ae6dfba5c357
Autor:
Johnny W. Peterson, Elbert B. Whorton, Jason E. Comer, William S Lawrence, Satheesh K Sivasubramani, Dallas Hughes, Losee L Ling, David W.C. Beasley, Jennifer E. Peel, Wallace B. Baze
Publikováno v:
Pathogens, Vol 9, Iss 773, p 773 (2020)
Pathogens
Volume 9
Issue 9
Pathogens
Volume 9
Issue 9
The use of antibiotics is a vital means of treating infections caused by the bacteria Bacillus (B.) anthracis. Importantly, with the potential future use of multidrug-resistant strains of B. anthracis as bioweapons, new antibiotics are needed as alte
Autor:
Terry L. Juelich, Satheesh K Sivasubramani, Olivier Escaffre, Alexander N. Freiberg, Jennifer E. Peel, Terence E. Hill, Jennifer K. Smith, Tetsuro Ikegami, Benhur Lee, William S Lawrence, Colm Atkins, David E Perez, Arnold Park, Johnny W. Peterson, Lihong Zhang
Publikováno v:
The Journal of Infectious Diseases. 218:1602-1610
Background Nipah virus (NiV) is a paramyxovirus (genus Henipavirus) that can cause severe respiratory illness and encephalitis in humans. Transmission occurs through consumption of NiV-contaminated foods, and contact with NiV-infected animals or huma
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Thomas W. Geisbert, Viktoriya Borisevich, William S Lawrence, Satheesh K Sivasubramani, Krystle N. Agans, Chad E. Mire, Abhishek N. Prasad, Karla A. Fenton, Joan B. Geisbert
Publikováno v:
The Journal of infectious diseases. 221(Suppl 4)
The high case-fatality rates and potential for use as a biological weapon make Nipah virus (NiV) a significant public health concern. Previous studies assessing the pathogenic potential of NiV delivered by the aerosol route in African green monkeys (
Autor:
Vladimir L. Motin, Bethany L. Tiner, Elena V. Kozlova, Snehal S. Patel, Jian Sha, Jennifer E. Peel, Michelle L. Kirtley, William S Lawrence, Ashok K. Chopra, Satheesh K Sivasubramani, Johnny W. Peterson, Igor Patrikeev, Tatiana E. Erova, Jourdan A. Andersson, Duraisamy Ponnusamy, David McWilliams, Wallace B. Baze, Curtis Klages, Eric C. Fitts, Maxim V. Telepnev, Eric Rothe
Publikováno v:
Clinical and Vaccine Immunology. 23:586-600
Currently, no plague vaccine exists in the United States for human use. The capsular antigen (Caf1 or F1) and two type 3 secretion system (T3SS) components, the low-calcium-response V antigen (LcrV) and the needle protein YscF, represent protective a